Implant Procedure To Mark The End Of The Traditional AV Fistula And Graft For Dialysis Patients

av fistula.jpeg

For people with Chronic Kidney Disease (CKD), healthcare professionals and organizations alike have agreed that the Arteriovenous (AV) fistula is the "gold standard" (best type) of vascular access, followed only by the synthetic graft for CKD patients on Hemodialysis. This is because the fistula has low rates of complications, clotting and infection. However, the new ready-to-use bioengineered blood vessels appear to be a safe and better substitute for the synthetic graft and even the AV fistula, according to results from trials that were presented at the American Heart Association on November 20, 2013.

Recommended Reading: New Implant Procedure Is "Good News" For Chronic Kidney Disease Patients 

Jeffrey H. Lawson, MD, PhD (Duke University Medical Center) suggested that the artificial bioengineered veins not only further minimized the risk of clotting and infection, but also reduced the chance of "rejection." This "off-the-shelf" vein is built by cultivating human cells on a tubular scaffold to form a vessel-like shape which is then scrubbed clean of qualities that can trigger immune responses once it is implanted into a dialysis patient's arm. 

Recommended Reading: Obstruction in AV Fistula can cause Dialysis Patients to Lose Fingers or even a Hand 

After a human trial, researchers found that the vein proved mechanically similar to native vessels and after 6 months there was adequate flow in all patients with no evidence of immune reaction, infection or signs of aneurysms. While Dr.

Lawson noted that longer follow-up and additional clinical studies are required to confirm preliminary observations, a notable milestone has been reached. The U.S. Food and Drug Administration has approved an Investigational New Drug application to evaluate the bioengineered vessels in a multicenter U.S. trial of CKD patients undergoing Hemodialysis. 

Recommended Reading: CKD on Dialysis should make checking Fistula "Buzz" a Daily Practice 

If the bioengineered veins prove effective and safe, KidneyBuzz.com believes it will be great news for the CKD Community who choose Hemodialysis as their main modality and currently deal with blocked veins from clotting, additional surgical procedures and high risk of infection when harvesting veins for a fistula or graft.

PURCHASE YOUR $5.00 "NO BLOOD PRESSURE (BP)/NO NEEDLE STICK (STICK)" MEDICAL ALERT BRACELET TO PROTECT YOUR FISTULA FROM FAILURE AND SUPPORT KIDNEYBUZZ.COM.

PURCHASE YOUR $5.00 "NO BLOOD PRESSURE (BP)/NO NEEDLE STICK (STICK)" MEDICAL ALERT BRACELET TO PROTECT YOUR FISTULA FROM FAILURE AND SUPPORT KIDNEYBUZZ.COM.

Note: Do not forget to order your No BP/No Stick Medical Alert Bracelet!   

Like Us on our Facebook Page for more Daily News and Information about life with CKD and ESRD:

https://www.facebook.com/pages/KidneyBuzz/347471888696381?ref=hl


Most Popular Stories:

Three New Technological Advancements That Are Significantly Changing CKD Patients' Lives Today
New Health Challenges Facing Chronic Kidney Disease Patients: How To Successfully Cope
Recent Artificial Kidney Update Provides Chronic Kidney Disease Patients Most Promising News Yet

References:

Dalton, Kim. "Bioengineered Vessels Appear Safe for Use in Dialysis Patients - Journal News - TCTMD." Http://www.tctmd.com/. American Heart Association Scientific Sessions;

Laino, Charlene, Medpage Today and Everyday Health Staff Writer. "First Bioengineered Blood Vessel Implant Is a Success." Http://www.everydayhealth.com/. EverydayHealth Media, LLC